Report overview
This report contains market size and forecasts of Pharmacodynamic (PD) Biomarkers in Global, including the following market information:
Global Pharmacodynamic (PD) Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmacodynamic (PD) Biomarkers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Exposure Biomarkers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmacodynamic (PD) Biomarkers include Thermo Fisher Scientific, Merck, Bio-Rad Laboratories, QIAGEN, Roche, Danaher Corporation, Siemens Healthcare, Abbott and Agilent Technologies. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharmacodynamic (PD) Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmacodynamic (PD) Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmacodynamic (PD) Biomarkers Market Segment Percentages, by Type, 2021 (%)
Exposure Biomarkers
Effect Biomarkers
Susceptibility Biomarkers
Global Pharmacodynamic (PD) Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pharmacodynamic (PD) Biomarkers Market Segment Percentages, by Application, 2021 (%)
Diagnostics
Drug Discovery
Personalized Medicine
Others
Global Pharmacodynamic (PD) Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pharmacodynamic (PD) Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmacodynamic (PD) Biomarkers revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmacodynamic (PD) Biomarkers revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
